Lanean...
Antibody Drug Conjugates: Preclinical Considerations
The development path for antibody drug conjugates (ADCs) is more complex and challenging than for unmodified antibodies. While many of the preclinical considerations for both unmodified and antibody drug conjugates are shared, special considerations must be taken into account when developing an ADC....
Gorde:
| Argitaratua izan da: | AAPS J |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer US
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406963/ https://ncbi.nlm.nih.gov/pubmed/25724883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-015-9738-4 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|